A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.
Michael DuerrEva V SchrezenmeierLukas J LehnerLéon BergfeldPetra GlanderStephan R Marticorena GarciaChristian E AlthoffIngolf SackSusanne BrakemeierKai-Uwe EckardtKlemens BuddeFabian HalleckPublished in: BMC nephrology (2019)
Registry name: European Clinical Trials Register; Trial registry number (Eudra-CT): 2014-004551-32 , Registration date: Aug 28th 2015.
Keyphrases
- hepatitis c virus
- clinical trial
- human immunodeficiency virus
- phase ii
- phase iii
- study protocol
- computed tomography
- hepatitis c virus infection
- dual energy
- image quality
- contrast enhanced
- positron emission tomography
- open label
- combination therapy
- double blind
- randomized controlled trial
- magnetic resonance
- drug induced
- hiv infected
- pet ct
- antiretroviral therapy